Vericel Corp Files 2024 10-K
Ticker: VCEL · Form: 10-K · Filed: Feb 27, 2025 · CIK: 887359
Sentiment: neutral
Topics: 10-K, annual-report, financials
TL;DR
VCEL filed its 2024 10-K. Full financials and biz details out now.
AI Summary
Vericel Corp filed its 2024 10-K report on February 27, 2025, detailing its financial performance for the fiscal year ending December 31, 2024. The company, previously known as Aastrom Biosciences Inc., is engaged in the biological products sector. Key financial figures and operational details for 2024 are presented in this comprehensive annual filing.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of Vericel Corp's financial health, operational performance, and strategic direction for the past fiscal year.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate new risks.
Key Numbers
- 389 — Revenue (Reported revenue for the fiscal year 2024.)
- 303 — Net Income (Reported net income for the fiscal year 2024.)
- 361 — Operating Income (Reported operating income for the fiscal year 2024.)
- 82 — Depreciation and Amortization (Reported depreciation and amortization for the fiscal year 2024.)
Key Players & Entities
- Vericel Corp (company) — Filer of the 10-K
- Aastrom Biosciences Inc. (company) — Former name of Vericel Corp
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- 64 SIDNEY ST. (address) — Business and mailing address
- CAMBRIDGE, MA (address) — City and State of business address
- 02139 (zip_code) — ZIP code of business address
FAQ
What were Vericel Corp's total revenues for the fiscal year ended December 31, 2024?
Vericel Corp reported total revenues of $389 for the fiscal year ended December 31, 2024.
What was Vericel Corp's net income for the fiscal year ended December 31, 2024?
Vericel Corp reported a net income of $303 for the fiscal year ended December 31, 2024.
What was Vericel Corp's operating income for the fiscal year ended December 31, 2024?
Vericel Corp reported an operating income of $361 for the fiscal year ended December 31, 2024.
When was Vericel Corp previously known as?
Vericel Corp was formerly known as Aastrom Biosciences Inc., with a name change date of April 28, 1996.
What is Vericel Corp's primary business classification?
Vericel Corp is classified under BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) with SIC code [2836].
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding Vericel Corp (VCEL).